Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Share-based Compensation (2018 - 2025)

Neurogene (NGNE) has disclosed Share-based Compensation for 5 consecutive years, with $3.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation changed N/A year-over-year to $3.4 million, compared with a TTM value of $13.3 million through Sep 2025, changed N/A, and an annual FY2024 reading of $8.3 million, up 486.74% over the prior year.
  • Share-based Compensation was $3.4 million for Q3 2025 at Neurogene, down from $3.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.0 million in Q1 2025 and bottomed at $1.0 million in Q1 2024.